terfenadine has been researched along with Cardiovascular Diseases in 3 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C | 1 |
| Wang, DW | 1 |
| Pratt, CM | 1 |
| Ruberg, S | 1 |
| Morganroth, J | 1 |
| McNutt, B | 1 |
| Woodward, J | 1 |
| Harris, S | 1 |
| Ruskin, J | 1 |
| Moye, L | 1 |
| Shaikh, WA | 1 |
1 review available for terfenadine and Cardiovascular Diseases
| Article | Year |
|---|---|
CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
Topics: 8,11,14-Eicosatrienoic Acid; Cardiovascular Diseases; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzy | 2013 |
2 trials available for terfenadine and Cardiovascular Diseases
| Article | Year |
|---|---|
Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.
Topics: Aged; Analysis of Variance; Anti-Allergic Agents; Cardiovascular Diseases; Cross-Over Studies; Dose- | 1996 |
The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
Topics: Cardiovascular Diseases; Drug Interactions; Electrocardiography; Erythromycin; Female; Histamine H1 | 2000 |